"Horiba" erythrolytic agent (unsterilized) - Taiwan Registration 2bce6a1308cc94ef22cd0f758df1e909
Access comprehensive regulatory information for "Horiba" erythrolytic agent (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 2bce6a1308cc94ef22cd0f758df1e909 and manufactured by HORIBA ABX SAS. The authorized representative in Taiwan is HORIBA TAIWAN, INC..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including HORIBA ABX SAS, and 3 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
Limited to the classification and grading management measures for medical devices, the first level identification range of "red blood cell lytic agent (B.8540)".
B Hematology, pathology, and genetics
B.8540 ็ด ่ก็ๆบถ่งฃๅ
QMS/QSD;; ่ผธๅ ฅ
Dates and Status
Nov 17, 2022
Nov 17, 2027
"Horiba" erythrolytic agent (unsterilized)
HORIBA ABX SAS
a4b02c64d04bd21d1c1c85ddc85f0020
1
"Horiba" erythrolytic agent (unsterilized)
HORIBA ABX SAS
84d19f6d0ad161a875c1083c54f84719
1
"Horiba" erythrolytic agent (unsterilized)
HORIBA ABX SAS
91f474773973f4b20a0700cc85458ff6
1

